QuiaPEG Pharmaceuticals Holding AB logo

QUIA - QuiaPEG Pharmaceuticals Holding AB Share Price

SEK2.73 0.0  0.7%

Last Trade - 3:18pm

Sector
Industrials
Size
Micro Cap
Market Cap £12.7m
Enterprise Value £13.7m
Revenue £n/a
Position in Universe 1416th / 1785
Bullish
Bearish
Unlock QUIA Revenue
Momentum
Relative Strength (%)
1m +2.14%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -26.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
9.33 2.64 1.99 0.000 0.000 0.000 6.00 6.00 -100.0%
+3,114
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the three months ended 31 March 2020, QuiaPEG Pharmaceuticals Holding AB revenues was not reported. Net loss increased 91% to SEK5.7M. Higher net loss reflects Other External Expenses increase of 66% to SEK2.7M (expense), Interest expense and similar items increase from SEK209K to SEK598K (expense), Depreciation/Amortization increase from SEK80K to SEK289K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

QUIA Revenue Unlock QUIA Revenue

Net Income

QUIA Net Income Unlock QUIA Revenue

Normalised EPS

QUIA Normalised EPS Unlock QUIA Revenue

PE Ratio Range

QUIA PE Ratio Range Unlock QUIA Revenue

Dividend Yield Range

QUIA Dividend Yield Range Unlock QUIA Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
QUIA EPS Forecasts Unlock QUIA Revenue
Profile Summary

QuiaPEG Pharmaceuticals Holding AB is a Sweden-based biotechnology company. The Company develops improved versions of clinically validated biopharmaceutical drugs based on PEGylation technology platform. The Company’s technology is applicable on proteins, peptides and small molecules and offers a half-life extension platform consisting of covalent, as well as extended release PEGylation. The Company focuses on development of long-acting biopharmaceuticals for the treatment of metabolic disorders. The main project intends to reduce the frequent injection therapy by requiring significantly fewer injections. The Company offers out-licensing and partnering opportunities. It has a patent portfolio with patents pending and an approved the United States patent covering chemical linkers.

Directors
Last Annual December 31st, 2019
Last Interim March 31st, 2020
Public Since June 21, 2005
No. of Shareholders: n/a
No. of Employees: 8
Sector Industrials
Industry Professional & Commercial Services
Index
Exchange AktieTorget Stock Exchange
Shares in Issue 53,658,594
Free Float (0.0%)
Eligible for
ISAs
SIPPs
QUIA Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for QUIA
Upcoming Events for QUIA
Frequently Asked Questions for QuiaPEG Pharmaceuticals Holding AB
What is the QuiaPEG Pharmaceuticals Holding AB share price?

As of 3:18pm, shares in QuiaPEG Pharmaceuticals Holding AB are trading at SEK2.73, giving the company a market capitalisation of £12.7m. This share price information is delayed by 15 minutes.

How has the QuiaPEG Pharmaceuticals Holding AB share price performed this year?

Shares in QuiaPEG Pharmaceuticals Holding AB are currently trading at SEK2.73 and the price has moved by -18.53% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the QuiaPEG Pharmaceuticals Holding AB price has moved by -14.45% over the past year.

What are the analyst and broker recommendations for QuiaPEG Pharmaceuticals Holding AB?

There are no analysts currently covering QuiaPEG Pharmaceuticals Holding AB.

When will QuiaPEG Pharmaceuticals Holding AB next release its financial results?

QuiaPEG Pharmaceuticals Holding AB is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the QuiaPEG Pharmaceuticals Holding AB dividend yield?

QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.

Does QuiaPEG Pharmaceuticals Holding AB pay a dividend?

QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.

When does QuiaPEG Pharmaceuticals Holding AB next pay dividends?

QuiaPEG Pharmaceuticals Holding AB does not currently pay a dividend.

How do I buy QuiaPEG Pharmaceuticals Holding AB shares?

To buy shares in QuiaPEG Pharmaceuticals Holding AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of QuiaPEG Pharmaceuticals Holding AB?

Shares in QuiaPEG Pharmaceuticals Holding AB are currently trading at SEK2.73, giving the company a market capitalisation of £12.7m.

Where are QuiaPEG Pharmaceuticals Holding AB shares listed? Where are QuiaPEG Pharmaceuticals Holding AB shares listed?

Here are the trading details for QuiaPEG Pharmaceuticals Holding AB:

Country of listing: Sweden
Exchange: AKT
Ticker Symbol: QUIA
What kind of share is QuiaPEG Pharmaceuticals Holding AB?

Based on an overall assessment of its quality, value and momentum, QuiaPEG Pharmaceuticals Holding AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a QuiaPEG Pharmaceuticals Holding AB share price forecast 2020?

We were not able to load any forecast data for QuiaPEG Pharmaceuticals Holding AB.

How can I tell whether the QuiaPEG Pharmaceuticals Holding AB share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like QuiaPEG Pharmaceuticals Holding AB. Over the past six months, the relative strength of its shares against the market has been 23.99%. At the current price of SEK2.73, shares in QuiaPEG Pharmaceuticals Holding AB are trading at 2.85% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the QuiaPEG Pharmaceuticals Holding AB PE Ratio?

We were not able to find PE ratio data for QuiaPEG Pharmaceuticals Holding AB.

Who are the key directors of QuiaPEG Pharmaceuticals Holding AB?

QuiaPEG Pharmaceuticals Holding AB's management team is headed by:

Johan von Kantzow - DRC
Lars Linzander - DRC
Jouni Tukiainen - CEX
Marcus Bosson - CEO
Marek Kwiatowski - DRC
Jonas Jarvius - DRC
Christian Krog-Jensen - DRC
Steen Kroyer - CHM
Cecilia Kemi - COO
Who are the major shareholders of QuiaPEG Pharmaceuticals Holding AB?

Here are the top five shareholders of QuiaPEG Pharmaceuticals Holding AB based on the size of their shareholding:

Similar to QUIA
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.